Jarrod Longocor

Company: Cellectar Biosciences
Job title: Chief Business Officer
Seminars:
Moving Beyond Solid Tumors: A Novel Radiotherapy in Hematologic Cancers 4:00 pm
Understanding Phospholipid ethers (PLE)s as a novel radioconjungate platform (PRCs) Review of Bexxar and Zevalin in hematologic cancers: Successes and challenges Highlights of PRCs data and methods to overcome challengesRead more
day: Day One